Dr. Ilian Iliev

Dr. Ilian Iliev is CEO of NetScientific and Managing Director of EMV Capital, which is a fully-owned subsidiary of NetScientific. Co-founded by Ilian, EMV Capital an award-winning VC investor specialising in early stage high-growth deep tech companies in the life science, sustainability and industrials sectors in the UK and internationally.

Prior to that he co-founded and was CEO of CambridgeIP Ltd (2006-2012), which he built into a leading market and technology business intelligence provider in the UK. He is a Board member at a number of NetScientific Group portfolio companies, including PDS Biotechnology, Glycotest, Sofant Technologies, Pointgrab, Q-Bot, Wanda Health, and also serves as Executive Chairman at Vortex Biosciences.

Ilian holds a PhD from Cambridge University’s Judge Business School, focused on Venture Capital business models in emerging economies; MCom in Economics, and BA in Politics, Economics and International Relations from the University of Witwatersrand. He has published widely on issues in the energy, healthcare, innovation finance and entrepreneurship. He is a former Associate Fellow at Chatham House, focused on energy and resource efficiency.

Dr. Ilian Iliev | Glycotest Diagnostics